Welcome, Introduction and Program Overview



Andrea Easom, MA, MNSC, APRN, BC, CNN
Please make sure that all slide images load before starting the lecture

Flash Player
Either option should work well.
Option 1 Progressive download Video/Audio
Option 2 Streaming Video/Audio

Windows Media Player
Option 1 Streaming Server
Option 2 For slow connections, right click on preload icon and choose "save target as". Play file from saved location.

Real Audio Player
Option 3 Streaming, Firewall-friendly
Option 4 Preload (2-5 mB)

Audio FAQ
For problems and suggestions, please click on this link.
This satellite symposium is sponsored by an unrestricted educational grant from Watson Pharma, Inc. This activity has been planned and produced in accordance with CE guidelines and policies. From a CE symposium held on April 5, 2006 at the American Nephrology Nurses' Association (ANNA) Annual Meeting in Nashville, TN. This symposium was approved by ANNA. It was not part of the official ANNA Annual Meeting.
This activity provides 1.8 contact hours. The American Nephrology Nurses’ Association (ANNA) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. ANNA is a Provider approved by the California Board of Registered Nursing, provider number CEP 00910.
Posting Date: September 15, 2006
CE Credit Eligible Through: September 15, 2008
CE Credit Hours/Completion Time: 1.8
Target Audiences: Nurses, nurse practitioners, and other healthcare professionals who treat and manage patients with CKD.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the post-test, read the linked abstracts in the post-test answer feedback material.
 
LEARNING OBJECTIVES:
The educational objectives for this talk are presented on the conference page. To view the objectives, click here.
SPEAKER DISCLOSURE STATEMENT:
Andrea Easom, MA, MNSc, APN, BC, CNN, is a member of the Speakers Bureau for Watson Pharma, Inc., Abbott, Amgen, and Pfizer.
No disclosed off-label use.


SPONSORSHIP / SUPPORT :
This ANNA Satellite symposium was developed in conjunction with Fallon Medica and ANNA, and sponsored by a restricted educational grant from Watson Pharma, Inc.

ANNA AND HDCN CE POLICY STATEMENTS:
The CE policy and disclosure statements of ANNA are given in detail on the Symposium Home Page. The CE policy statements of HDCN are listed on this page.

Ms. Andrea Easom:
I think the wonderful thing about ANNA meetings is, even though I have been in this for 30 years, I always come back with some things that make me go - hmmm...-, and things that validate my practice and things that challenge my practice. So I am always happy to speak to nephrology nurses because I am very biased and I think we are some of the most wonderful people in the whole wide world. We take care of some of the sickest patients in the whole wide world. The only constant I found in my 30 years of nephrology nursing is change. I know that many of us are going through a lot of changes with the changes in the industry. We are going to talk this morning about something that has been undergoing a lot of change, and we have new guidelines that are coming out. I am honored today.

I am Andrea Easom. I have been a member of ANNA since I cannot remember when, but it was back in the 1970s. I started in Nephrology in 1976. I have had the pleasure of serving you all at the national level as Legislative Chairperson and also Head of the Advance Practice SIG. I have held every... that is not true... I have never been Secretary. We have run ANNA out of my office for a long time back in the early days, and I am still Health Policy State Director for Arkansas, and so I stay active and I love speaking to ANNA audiences. You can see from all the alphabet soup behind my name that I have lots of degrees, and I want to encourage those of you all who are in school and those of you who sat for the certification exams, that all of those letters are really worth it. I started out in Nephrology as an Associate Science Nurse and now I am a Family Nurse Practitioner, and my role at the University of Arkansas, where I have been my whole career, is to teach physicians. I have Nephrology Fellows that are with me 1 month out of every year of their Fellowship, and my responsibilities with them are all stages of CKD. So, if you get somebody from the University of Arkansas and they are acting up, you can call me and I will talk to them! It shows you where you can go and I think that is what we need to be realizing, how much we mean to the profession, to our patients, and to our colleagues at all levels.

I am very honored to share the podium today with Debbie Bowe, who is a Clinical Administrator with the Kidney Institute of Wisconsin in their Northeast Unit. She also serves us as a Representative to the Renal Network 11 Medical Case Review Committee, which is going to be more and more important as we look at outcomes and pay-for-performance. She is President of the Wisconsin Chapter of ANNA, and she has co-authored several journal articles, and one of them she is going to be presenting today when I get through.



NEXT TALK ( Ms. Easom )